PODD vs BSX

	PODD Insulet Corp	BSX Boston Scientific Corp
Price	$148.12	$46.01
Sector	Health Care	Health Care
X-Ray Score	72	67
Valuation	68	79
Growth	91	89
Profitability	64	45
Financial health	67	55
Dividends	–	–
Fair value	$210	$62
Verdict	Undervalued +42%	Undervalued +35%
Revenue (TTM)	$3.1B	$21.0B
Operating margin	16.9%	19.8%
Return on capital	21.3%	10.1%
Revenue growth (3y)	27.5%	16.5%
Free-cash-flow yield	2.9%	5.3%
Net debt / EBITDA	0.7×	2.2×
Dividend yield	None	None

Scores and fair values are model estimates from SEC filings, ranked within each company's own sector, so scores of companies in different sectors are not directly comparable. Educational only, not financial advice.